AzTrials
AzTrials

Breast Self-ExaminationBreastSelfExamNCT05995483

Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day

A study testing Early Diagnosis on BSE in people with Breast Self-Examination and Breast Cancer, run by Eastern Mediterranean University at 1 site in Cyprus.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

H0: Among the intervention and control groups of reminder notifications relating to self-examination H01: Average breast cancer fear score and H02: There is no difference in the average score of breast cancer health beliefs. Read more about this study

Who is it for?
Ages 18 to 30 years, women onlyHealthy volunteers can take part
What is being tested?
Early Diagnosis on BSE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteCyprus
Study dates
4 Apr 2023to 4 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Who is over 18 years old,
  • Eastern Mediterranean University and Girne American University, newly enrolled female students in the Nursing Department of the Faculty of Health Sciences

Who cannot join

  • People who do not meet the criteria

Trial locations and contacts

1 site in 1 country.

Cyprus1 site
  • Eastern Mediterranean University & Girne American University

    Kyrenia

Other trials in Cyprus

About this study

Official title: Kendi Kendine Meme Muayenesi Ile İlgili Anımsatıcı Bildirimlerin Meme Kanseri Korkusu ve Sağlık İnançları Üzerine Etkisi/The Effect of Reminder Notifications About Breast Self-Exam on Fear of Breast Cancer and Health Beliefs

H0: Among the intervention and control groups of reminder notifications relating to self-examination

H01: Average breast cancer fear score and H02: There is no difference in the average score of breast cancer health beliefs.

H1: Among the intervention and control groups of reminder notifications relating to self-examination

H11: Average breast cancer fear score H12: Breast cancer is different in terms of average score of health beliefs

Read the detailed description

Newly Enrolled Students in the Nursing Programs at Girne American University and Eastern Mediterranean University Will Participate in This Study as an Experimental Study With a Pretest/Posttest Control Group. The Students Will Receive the Same Training. Contrary to the Control Group, the Intervention Group Will Have the System Which Will Send Reminder Notifications (Via the Web Base) Directing Them to the Website Containing BSE Training, Along With the Vector Illustration to be Created for the Concurrent Practice Prepared by the Researcher on the Determined Ideal Day. Users Will Receive a Notification Twice Via the Website and Email That Includes Re-examination Seven Days Following the End of Their Period. Depending on the Permission They Grant to Their Phones, Users Will be Able to Access the BSE Training Materials on the Website by Clicking on the General Reminder Notification or the Router, Using Their Browsers, and Logging in to Their Accounts. The Data on the Frequency of BSE With the "Breast Cancer Fear Scale" and "Champion's Health Belief Model Scale" Will be Collected From the Users at the End of the Three-month Period of Using the Website, Which Will be Developed in Order to Raise the Chances of Early Diagnosis by Encouraging BSE.

Being tested
Early Diagnosis on BSE
Keywords
Awareness, Early Diagnosis, Prevent Surgery, Breast Self-Examination
Medical subject headings
Breast Self-Examination, Breast Neoplasms, Neoplasms, Sleep Initiation and Maintenance Disorders, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Diagnosis on BSEOther

    the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day.

Study groups in NCT05995483
Study groupRoleWhat they receive
Have access to web based BSE training and notificationsExperimentalHave the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day.
Receives: Other: Early Diagnosis on BSE
Has no intervention during the studyNo interventionOnly has an powerpoint training og BSE, not knowing about the web base system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the health belief scores on 'Champion Health Belief Model Scale' and 'Breast Cancer Fear Scale' related web based BSE examination notifications in 3 months.

    Measuring the health belief on breast cancer early diagnosis and awareness with web based bse training and notifications using 'Champion Health Belief Model Scale' and 'Breast Cancer Fear Scale'.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2023
  2. Study start4 Apr 2023
  3. Primary completion4 Sep 2023 (estimated)
  4. Study completion4 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05995483
Sponsor's protocol ID
ETK00-2022-0030
Acronym
BreastSelfExam
Status last verified
Aug 2023
First submitted
18 Jul 2023
Last updated
16 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Early Diagnosis on BSE in people with Breast Self-Examination and Breast Cancer, run by Eastern Mediterranean University at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the health belief scores on 'Champion Health Belief Model Scale' and 'Breast Cancer Fear Scale' related web based BSE examination notifications in 3 months. (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2023; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in